Patient Information Leaflet Translation
A patient information leaflet has to be translated into Maltese with a level of precision that ordinary marketing or general document translation doesn't require, dosage instructions, contraindications, and side effect descriptions need to use exact pharmacological and medical terminology, not an approximate general-language equivalent, and both the source and translated leaflet need to follow the specific structure and mandatory sections a medicines regulator expects to see. A translation error in a PIL isn't a stylistic issue, an imprecise rendering of a dosage instruction or a missed contraindication can directly affect patient safety, and it's also one of the more heavily scrutinized documents in a regulatory submission, where a translation inconsistency between the English and Maltese versions can hold up an approval.
STARTING PRICE
From €799
Complex tier · Multi-system orchestration, custom logic, and higher-volume or higher-risk processing.
Get a quote →Saves roughly 8-15 hrs per leaflet translation and review cycle, plus reduced risk of a regulatory hold from a translation or formatting gap.
How the automation works
We translate patient information leaflets into Maltese using a maintained pharmacological and medical terminology glossary specific to your product category, so dosage, contraindication, and side-effect language uses the precise clinical term rather than an approximate general translation, and every translated leaflet is checked against the mandatory structure and section requirements the Maltese medicines authority expects. Every translation goes through review by a bilingual reviewer with relevant medical or pharmaceutical background before it's finalized, since this content sits well outside the tolerance for the kind of ambiguity acceptable in general translation, and the English and Maltese versions are cross-checked specifically for substantive consistency, not just parallel structure, so a regulator comparing the two finds them saying the same thing. Terminology consistency is checked against the Malta Medicines Authority's approved glossary rather than general medical dictionaries, since regulator-specific terminology choices can differ from standard clinical translation conventions in ways that matter for approval.
Process flow
- 01
Extract source PIL content trigger
The approved English patient information leaflet content is extracted, structured by its mandatory regulatory sections.
- 02
Translate with clinical terminology ai
Content is translated into Maltese using a maintained pharmacological and medical terminology glossary, ensuring precise clinical language for dosage, contraindications, and side effects.
- 03
Check mandatory structure compliance ai
The translated leaflet is checked against the mandatory section structure the Maltese medicines authority requires, flagging any missing or misordered required content.
- 04
Route for specialist bilingual review output
The translation routes to a bilingual reviewer with relevant medical or pharmaceutical background for accuracy verification before finalization.
- 05
Cross-check substantive consistency ai
The English and Maltese versions are cross-checked for substantive consistency in meaning, not just matching structure, flagging any material divergence.
Inputs
- Approved English patient information leaflet
- Maintained pharmacological/medical terminology glossary
- Maltese medicines authority formatting requirements
- Specialist bilingual reviewer assignments
Outputs
- Clinically precise Maltese leaflet translation
- Structure compliance verification
- Specialist-reviewed final translation
- Substantive English-Maltese consistency check
Works with
Prefer a fully custom build instead of an off-the-shelf integration? We scope both options during your free consultation — most jobs like this one work fine on standard connectors, but higher-volume or non-standard systems sometimes need bespoke API work, reflected in the complex tier.
Where this goes wrong if you get it wrong
- An approximate or general-language translation of a dosage instruction or contraindication is not an acceptable substitute for the precise clinical term in this content type, unlike marketing copy where a close paraphrase is fine, patient safety-relevant language needs to use the exact pharmacological terminology a healthcare professional or patient would expect, and a maintained clinical glossary specific to the product category is what makes that consistent across translations.
- This process handles translation and regulatory formatting compliance, it does not make the underlying clinical or regulatory content decisions, what the leaflet actually needs to say about dosage, contraindications, and warnings comes from your regulatory affairs and clinical teams, translation has to faithfully render that approved content, not reinterpret it.
- A structural requirement missed in translation, a mandatory section reordered or a required warning statement omitted because it didn't translate cleanly, can hold up regulatory approval on a formatting technicality even when the clinical content itself was translated accurately, structure compliance needs its own explicit check separate from content translation accuracy.
- General bilingual review, someone fluent in both languages but without pharmaceutical or medical background, isn't sufficient for this content type, review needs specifically someone who can verify that the clinical terminology is not just grammatically correct Maltese but the actual term a Maltese healthcare professional or patient would recognize and expect.
Frequently asked questions
Does this make clinical or regulatory content decisions about the leaflet?
No, the clinical content, dosage instructions, contraindications, warnings, comes from your regulatory affairs and clinical teams; this translates that approved content precisely and checks it against regulatory formatting requirements.
Who reviews the translated leaflet?
A bilingual reviewer with relevant medical or pharmaceutical background, not general bilingual staff, since verifying clinical terminology accuracy requires that specific expertise.
How does this ensure the English and Maltese versions say the same thing?
Beyond structural translation, the two versions are cross-checked specifically for substantive consistency in meaning, flagging any material divergence that a structural comparison alone would miss.
Does this follow Malta's specific medicines authority requirements for leaflet structure?
Yes, the translated leaflet is checked against the mandatory section structure and formatting the Maltese medicines authority requires for approval.